• Dr Bardia Akbari, Global Head Partnering Inflammation and Autoimmune, Roche Pharma Partnering
• Dr Susan Alder, Consultant, SJ Alder Pty Ltd
• Dr Zaheer Anjum, Acting Head, Office of Prescription Medicines, TGA
• Ms Kiara Bechta-Metti, Commercialisation Manager, CSIRO
• Dr Tom Beer, President, IUGG, Transport Biofuels Stream Leader, Energy Transformed Flagship, CSIRO
• Dr C.Glenn Begley, Vice President, Hematology Oncology Research, Amgen
• Mr Geoff Bell, Chief Executive Officer, Microbiogen
• Mr Hershel Berry, Founder & Managing Partner, Blueprint Life Sciences
• Dr Judy Bingham, Senior Director, Regulatory Consulting and Submissions Asia Pacific. Kendle
• Mr Hamish Blair, Senior Adviser, Leadenhall VRG
• Mr David Blake, Co-Editor, Bioshares
• Dr BJ Bormann, Senior Vice President, Business Development & Licensing, Boehringer Ingelheim
• Mr Christopher Boyer, Executive Director, Bio-Link
• Dr Arthur Brandwood, Managing Director, Brandwood Biomedical (part 2)
• Mr Garold Breit, Executive Director, University of Manitoba Technology Transfer Office
• Mr Peter Brenders, President & CEO, BIOTECanada (part 2)
• Dr Geoff Brooke, Co Founder & Managing Partner, GBS Venture Partners
• Mr Erinn Broshko, Chief Executive Officer, Med BioGene
• Ms Winna Brown, Australian Life Sciences Leader, Partner, Assurance Business Services, Ernst & Young
• Dr Tran Ngoc Ca, Deputy Director, Deputy Director, National Institute for S&T Policy and Strategy, Ministry of Science and Technology & Director, Secretariat, National Council for S&T Policy, Vietnam
• Dr Deborah Campbell, Executive Medical Director, Amgen Australia
• Ms Janelle Casey, Industry Team Leader, Health, Biotechnology & Wellbeing, Austrade
• Mr Jeffery Castellas, Chief Executive Officer, Clean Technology AustralAsia
• Dr Selena Chaisson, Director of Healthcare Investments, Bailard
• Mr Stephen Chandler, General Manager, Florigene (part 2, part 3)
• Dr Daniel Chelsky, Chief Scientific Officer, Caprion Proteomics
• Dr Benjamin Chen, Managing Director, Burrill & Company
• Mr Trevor Choy, Founder, Choy Lawyers
• Dr Stella Clarke, Chief Executive Officer, The Bio21 Cluster
• Ms Robin Coleman, Director, Advent Pharmaceuticals
• Mr Paul Cohen, Senior Consultant, Brandwood Biomedical
• Dr David Collier, Managing Director, CMEA Capital
• Mr Tony Conaghan, Practice Group Leader, DLA Phillips Fox
• Dr Ross Crittenden, R&D Manager, Biologics and Nutrition, MG Nutritionals, Project Leader, CSIRO - Food and Nutritional Sciences
• Mr Glenn Cross, Chief Operations Officer, AusBiotech
• Mr Grant Davidson, Managing Director, Davidson
• Dr Fred Davis, Managing Director, Invetech
• Dr Nick Day, Professor of Tropical Medicine, Oxford, and Director of the Mahidol Oxford Clinical Research Unit, Bangkok, Thailand
• Dr. Thomas Diefenthal, CEO, BioPark Regensburg, Germany(part 2, part 3)

• Ms Kerry Doyle, Acting Executive Director, Innovation, Research and Policy, Industry and Investment NSW
• Mr Stephen Edelson, Executive Editor, SciBx
• Mr Ian Edvalson, Partner, Wilson Sonsini Goodrich & Rosati
• Dr Les Edye, Principal Research Fellow, Biofuels & Biorefineries, QUT
• Mr Nick Evans, Editor, Biotechnology News
• Dr Leigh Farrell, Vice President Business Development, Biota Holdings
• Ms Lynnette Ferguson, Head Discipline of Nutrition, Faculty of Medical and Health Sciences, The University of Auckland
• Mr Gary Fitt, Deputy Chief, Entomology, CSIRO (Part 2)
• Mr Peter Francis, Partner, Francis Abourizk Lightfowlers
• Mr Lubor Gaal, Head of Europe Search, Bristol Myers Squibb
• Mr Andrew Geering, Principal Plant Pathologist, Industry Services, Queensland Primary Industries and Fisheries
• Dr Michael Gilbert, General Manager, Australian Centre for Plant Functional Genomics (part 2)
• Mr Keith Glasson, General Manager, Pioneer Hi-Bred Australia
• Dr Harvey Glick, Regional Scientific Affairs Lead, Monsanto
• Mr Andrew Goodsall, Senior Healthcare Analyst, UBS Australia
• Mr Lawrence Gozlan, CEO & Founder, Scientia Capital
• Dr Melissa Grady, Head of Clinical Research, Medical & Regulatory Affairs, AstraZeneca & Co-Chair PIC-RDTF (part 2, part 3)
• Dr Daniel Grant,Head of R&D Business Development, Australia, New Zealand, Singapore, Pfizer Global Research and Development
• Dr Michael Greenberg, Clinical Program Director, Vaccines Develpment, CSL
• Dr Lisa Haile, Partner, DLA Piper
• Dr Jennifer Hannesschlager, Managing Scientific Director, McKenna Long & Aldridge
• Dr Jenny Harry, CEO & Managing Director, Tyrian Diagnostics
• Mr Peter Havel, Director Medical Health Services (MHS) Group, TUV SUD, Japan (part 2)
• Dr Mark Heffernan, Chief Executive Officer, Opsona Therapeutics
• Ms Joy Hewitt, Director Business Development, Biota Holdings Limited
• Dr Sarah Holland, Global Head, CNS Partnering, Pharma Partnering, Hoffmann-La Roche
• Dr Christopher Holloway, Group Director of Regulatory Affairs, ERA Consulting
• Mr David Hudson, Managing Director, SGA Solutions (part 2)

• Dr Dianne Jackson-Matthews, Deputy Group Director of Regulatory Affairs, ERA Consulting
• Dr Phil Kearney, Director, Licensing & External Research, Merck, Sharpe and Dohme (Part 2)
• Mr Karl Kelly, Chief Executive Officer, Stirius (part 2 of presentation)
• Mr John Kelly
• Dr Andrew Kelly, Executive Director, BioPacific Ventures
• Dr Anna Lavelle, Chief Executive Officer, AusBiotech ltd
• Dr Bruce Lee, Director, Food Future Flagship, CSIRO
• Dr Robyn Lindner, Chief Scientific Officer, Tyrian Diagnostics
• Prof John Lovett, Chairman, CRC for National Plant Biosecurity
• Mr Matt McNamara, Chief Investment Officer, IB Fund
• Dr Andrew MacDonald, Chief Executive Officer, Cytopia
• Ms Sue MacLeman, Chief Executive Officer, Benitec
• Mr Doug McCartney, Director, Science Innovation and Business Development, Manitoba Government
• Dr Andrew Martin, Senior Lecturer, Biostatistics, NHMRC Clinical Trials Centre
• Mr Sean McKay, Executive Director, Composites Innovation Centre
• Mr Peter Molloy, President, Aquarius Consulting
• Dr Ana Maria Moreno, Research Associate, Corelli Consulting
• Dr Colleen Nelson, Executive Director, Australian Prostrate Cancer Research Centre
• Professor Lars Nielsen, Professor & Chair of Biological Engineering, Australian Institute of Bioengineering and Nanotechnology
• Dr Adrian Oates, Vice President, Quality & Regulatory, Universal Biosensors
• Mr Ian O'Hara, Senior Research Scientist and Theme Leader - Bioenergy Queensland University of Technology (QUT) Centre for Tropical Crops and Biocommodities (part 2)
• Ms Sue O'Malley, Consultant Reimbursement Strategist, Medical Intelligence
• Dr Elliot Parks, President and CEO, Hawaii Biotech Inc
• Prof Tony Peacock, Chief Executive, CRC for Invasive Animals (part 2)
• Mr Damian Perriman, Vice President Business Development, Verdezyne
• Ms Kate Phillips, Senior Associate, Baker & McKenzie
• Professor Susan Pond
• Mr Scott Power, Associate Director, Research, ABN AMRO Morgans
• Mr David Radford, Executive Director & CEO, Nanosonics
• Dr Deborah Rathjen, CEO & Managing Director, Bionomics
• Dr. Curtis Rempel, Research Development Manager, University of Manitoba (Part 2)
• Mr Craig Rogers,Chief Commercial Officer, Nucleus Network
• Mr Bjorn Roberts, Director of Intelligence and Consumer Safety, Australian Customs & Border Protection Service.
• Ms Beth Roberts, Partner, Hogan & Hartson LLP
• Dr Alan Robertson, Chief Executive Officer, Pharmaxis
• Dr Greg Roger, Chief Executive Officer, Advanced Surgical Design & Manfacturing Ltd
• Dr Jane Ryan, Vice President, Product Development, Biota Holdings Limited
• Mr Peter Sandbach, Head of Communications, Roche Pharma Partnering
• Mr Scott Sarazen, Global Life Sciences Markets Leader, Ernst & Young Boston
• Dr Ebenezer Satyarai, Senior Research Scientist, Nestle
• Dr Rens Scheepers, Associate Professor, Department of Information Systems, The University of Melbourne
• Mr Peter Schutz, Chief Executive, George Weston Technologies
• Mr Dale Seymour, Deputy Secretary, DIIRD
• Dr Sunny Sharma, Senior Managing Director, Asia, OrbiMed Advisors
• Ms Lynda Shelley, Executive Director, Clinical Operations, Novotech
• Dr Evan Siegel, President & Chief Executive Officer, Ground Zero Pharmaceuticals
• Mr Sajai Singh, Resident Partner, J.Sagar Associates
• Dr Danielle Smith, Project Manager, Medicines Development Ltd
• Dr Paul Tan, Chief Executive Officer, LCT
• Mr Ken Taylor, Private Investigator, Trade Mark Investigation Services
• Dr Niall Tebbutt, Consultant Medical Oncologist, Ludwig Institute for Cancer Research
• Mr David Theriault, Business Development Leader Emerging Technology, The DOW Chemical Company
• Associate Professor David Thomas, Peter MacCallum Institute for Cancer Research
• Dr Mervyn Thomas, Managing Director, Emphron Informatics
• Dr Ram A. Vishwakarma, Director, Indian Institute of Integrative Medicine (CSIR), Jammu, India (part 2).
• Mr Graeme Wald, Head of Life Sciences Research, Wilson HTM
• Mr Richard Walmsley, Chief Executive Officer, Ingeneus
• Dr Andrew Walter, Operations Manager, AH & GM Walter (part 2)
• Mr Stephen Walters, Chief Economist, J.P Morgan
• Dr Fintan Walton, Chief Executive & Founder, PharmaVentures
• Dr Linfa Wang, CEO Science Leader, CSIRO Livestock Industries (part 2, part 3)
• Dr Stewart Washer, Director, AusBiotech
• Mr Brad Wheatley, Research Leader, Environment, Boeing Australia
• Ms Elisabeth White, Partner, Baker & McKenzie
• Dr Greg Wiederrecht, Vice President and Head, External Scientific Affairs, Worldwide Licensing & External Research, Merck & Co
• Ms Rebecca Wilson, Principal, Buchan Consulting
• Dr Graeme Woodrow, Chief, Molecular and Health Technologies, CSIRO
• Mr Robert Wulff, Principal, Griffith Hack
• Dr Zeqi Zhou, Vice President, Tianjin International Joint Academy of Biotechnology and Medicine, PR China